Callan Family Office LLC Buys 11,075 Shares of CME Group Inc. $CME

Callan Family Office LLC raised its stake in shares of CME Group Inc. (NASDAQ:CME) by 431.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,639 shares of the financial services provider’s stock after purchasing an additional 11,075 shares during the quarter. Callan Family Office LLC’s holdings in CME Group were worth $3,759,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. Great Lakes Advisors LLC lifted its position in CME Group by 2.3% during the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after purchasing an additional 37 shares during the last quarter. Beaumont Financial Advisors LLC raised its stake in shares of CME Group by 2.0% during the second quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock worth $538,000 after acquiring an additional 38 shares in the last quarter. Trifecta Capital Advisors LLC raised its stake in shares of CME Group by 59.2% during the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after acquiring an additional 42 shares in the last quarter. OneAscent Financial Services LLC raised its stake in shares of CME Group by 4.0% during the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider’s stock worth $293,000 after acquiring an additional 43 shares in the last quarter. Finally, Highline Wealth Partners LLC raised its stake in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 43 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Up 1.0%

Shares of NASDAQ CME opened at $271.45 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The firm’s fifty day moving average is $268.89 and its 200 day moving average is $271.17. The company has a market cap of $97.83 billion, a price-to-earnings ratio of 26.28, a PEG ratio of 5.67 and a beta of 0.41.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.56 earnings per share. On average, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is presently 48.40%.

Analyst Upgrades and Downgrades

Several research analysts have commented on CME shares. Morgan Stanley lifted their price target on shares of CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 1st. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $246.00 to $252.00 and gave the stock an “underweight” rating in a research note on Thursday, September 25th. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research note on Wednesday. UBS Group decreased their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research note on Monday, September 8th. Finally, Piper Sandler lifted their target price on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 15th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus price target of $281.00.

Insider Activity at CME Group

In related news, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction on Thursday, September 25th. The shares were acquired at an average cost of $265.19 per share, with a total value of $69,479.78. Following the transaction, the director owned 258,459 shares in the company, valued at $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 in the last 90 days. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.